Phase III Study of CPX-351 Versus 7+3 in Patients 60-75 Years Old With Untreated High Risk (Secondary) Acute Myeloid Leukemia

Clinical trial NCT01696084 · COMPLETED

Trial details

NCT number: NCT01696084
Sponsor: Jazz Pharmaceuticals
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

High Risk Acute Myeloid Leukemia

Start date: 2012-12-13
Primary completion: 2015-12-31
Enrollment: 309

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.